AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
Rare diseases, which affect more than 300 million people worldwide, are often difficult to diagnose. Many patients wait five years or more for a correct diagnosis and are misdiagnosed at least once along this diagnostic odyssey. In addition to being a significant burden to patients’ well-being, low diagnostic rates also impact research and development in the rare disease space and challenge the success of marketed orphan drugs.
Read this Pro article free
Subscribe to BiopharmaTrend Insider, our free biweekly briefing on what matters in tech and bio, and get one free Pro article every month, starting with this one.
Insider arrives every two weeks, plus a short note when we publish a new deep dive. Unsubscribe anytime. Articles you unlock stay unlocked.
Topic: AI in Bio